ALX Oncology Inc.

ALXO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.62

-$0.04 (-2.41%)

Sep 22, 2026, 12:03 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	16.37M	17.57M	22.41M	48.82M	363.67M	434.22M
Short-Term Investments	28.42M	110.19M	160.33M	217.39M	n/a	n/a
Long-Term Investments	3.49M	3.52M	35.41M	16.7M	n/a	n/a
Other Long-Term Assets	3.63M	267K	7.64M	9.01M	9.69M	10K
Receivables	298K	892K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.64M	5.7M	5.92M	4.76M	n/a	n/a
Total Current Assets	50.73M	134.35M	188.66M	270.97M	367.02M	435.99M
Property-Plant & Equipment	1.2M	9.63M	10.84M	9.81M	3.47M	52K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.32M	13.42M	53.89M	35.52M	13.16M	62K
Total Assets	59.05M	147.78M	242.55M	306.49M	380.18M	436.05M
Account Payables	4.91M	4.5M	8.59M	8.07M	3.76M	4K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	5.22M	435K	n/a	n/a	n/a	n/a
Other Current Liabilities	14.42M	5.97M	6.7M	4.72M	3.53M	2.13M
Total Current Liabilities	24.55M	18.5M	36M	28.33M	15.3M	6.2M
Long-Term Debt	n/a	9.47M	9.64M	9.39M	n/a	n/a
Other Long-Term Liabilities	8.51M	1.03M	1.22M	5.31M	1.84M	5K
Total Long-Term Liabilities	8.51M	15.66M	16.84M	14.7M	1.84M	5K
Total Liabilities	33.07M	34.16M	52.84M	43.03M	17.13M	6.21M
Total Debt	5.22M	16.98M	17.2M	10.43M	742K	n/a
Book Value	25.98M	113.62M	189.71M	263.46M	363.05M	429.85M
Book Value Per Share	0.48	2.18	4.41	6.47	9.01	10.79
Common Stock	54K	53K	50K	41K	41K	40K
Retained Earnings	-722.82M	-621.12M	-486.27M	-325.47M	-201.99M	-118.52M
Comprehensive Income	28K	275K	256K	-845K	0	n/a
Shareholders Equity	25.98M	113.62M	189.71M	263.46M	363.05M	429.85M
Total Investments	31.91M	113.71M	195.74M	234.08M	n/a	n/a